Ms Fany Bonilla

Spring House (United States of America)

Follow

Contributor content

Comparison of the sensitivity of commercial aPTT tests in measurement of the pharmacodynamic response of milvexian, a novel FXIa inhibitor

Presentation

Comparison of the sensitivity of commercial aPTT tests in measurement of the pharmacodynamic response of milvexian, a novel FXIa inhibitor

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources